Literature DB >> 2787859

Splenic embolization in children: long-term efficacy.

C T Brandt1, L J Rothbarth, D Kumpe, F M Karrer, J R Lilly.   

Abstract

Eighteen partial splenic embolization procedures (PSEs) were performed in 17 children for hypersplenism (13) and/or esophageal variceal hemorrhage (12). The underlying disease was biliary atresia (BA) in nine children, portal vein thrombosis (PVT) in four, and biliary cirrhosis (BC) in four. From 20% to 90% of the spleen was embolized. Immediate morbidity was high, albeit minor, and the initial hospitalization was protracted for an average of 16 days. The children were followed from 4 to 81 months (average, 34.2). Four patients with BA patients subsequently had liver transplantation at an average of 20 months after PSE. In ten of 13 patients with hypersplenism, hematologic indexes returned to and remained normal throughout follow-up. The three exceptional patients (who had only 20%, 60% and 60% splenic embolization) developed recurrent mild hypersplenism, one of whom was reembolized and is free from hypersplenism 22 months later. Variceal hemorrhage was ameliorated in all 12 patients (average, 2.4 episodes of hemorrhage per year before PSE, 0.5 per year afterwards). Overwhelming postsplenectomy sepsis did not occur in an aggregate follow-up of 48.5 years. PSE is a legitimate treatment alternative for hypersplenism and for esophageal varices in children.

Entities:  

Mesh:

Year:  1989        PMID: 2787859     DOI: 10.1016/s0022-3468(89)80710-9

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  7 in total

1.  Significance of laparoscopic splenectomy in patients with hypersplenism.

Authors:  Yuji Watanabe; Atsushi Horiuchi; Motohira Yoshida; Yuji Yamamoto; Hiroki Sugishita; Teru Kumagi; Yoichi Hiasa; Kanji Kawachi
Journal:  World J Surg       Date:  2007-03       Impact factor: 3.352

2.  Partial splenic embolization in a child with hereditary spherocytosis.

Authors:  M Jiménez; C Azcona; L Castro; J I Bilbao; P León; L Sierrasesúmaga
Journal:  Eur J Pediatr       Date:  1995-06       Impact factor: 3.183

3.  Portal hypertensive gastropathy with portal thrombosis successfully treated with partial splenic embolization.

Authors:  Hisamitsu Miyaaki; Tatsuki Ichikawa; Kazuhiko Nakao; Shigeyuki Takeshita; Hidetaka Shibata; Eisuke Ozawa; Motohisa Akiyama; Satoshi Miuma; Masumi Fujimoto; Katsumi Eguchi
Journal:  Clin J Gastroenterol       Date:  2009-03-19

4.  Partial splenic embolization: long-term outcome.

Authors:  Birger Pålsson; Magnus Hallén; Annika Mandahl Forsberg; Anders Alwmark
Journal:  Langenbecks Arch Surg       Date:  2003-01-15       Impact factor: 3.445

Review 5.  Cirrhosis and other liver disease in cystic fibrosis.

Authors:  Thomas Flass; Michael R Narkewicz
Journal:  J Cyst Fibros       Date:  2012-12-20       Impact factor: 5.482

Review 6.  Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis.

Authors:  Massimo Bolognesi; Marco Di Pascoli; Alberto Verardo; Angelo Gatta
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

7.  <Editors' Choice> Long-term outcomes of the partial splenectomy for hypersplenism after portoenterostomy of patients with biliary atresia.

Authors:  Takahisa Tainaka; Akinari Hinoki; Yujiro Tanaka; Chiyoe Shirota; Wataru Sumida; Kazuki Yokota; Satoshi Makita; Kazuo Oshima; Hizuru Amano; Aitaro Takimoto; Yoko Kano; Hiroo Uchida
Journal:  Nagoya J Med Sci       Date:  2021-11       Impact factor: 1.131

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.